IG
Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations
With so many immune globulin products on the market, providers frequently have questions about the best approach to ...
JUNE 26, 2025
Forging Better Immune Globulin Outcomes
Two new studies presented at the IgNS 2024 National Conference offer insight into treatment options for immune ...
APRIL 27, 2025
Primary Immunodeficiency Treatment and Support
An FDA-cleared immunoglobulin infusion set aims to improve the experience of people with primary immunodeficiency ...
FEBRUARY 21, 2025
Sepsis: Tips for Early Identification and Home-Based Prevention
Sepsis remains a concern for people on immunoglobulin therapy, especially those receiving infusions at home, but ...
FEBRUARY 21, 2025
Pediatric OCD May Respond to IG Therapy
Las Vegas—Timely treatment with IVIG therapy may help children who develop obsessive-compulsive disorder ...
FEBRUARY 23, 2022
Navigating COVID-19 and Other IG Challenges
Las Vegas—A patient with primary immunodeficiency on immune globulin (IG) therapy receives the first and ...
FEBRUARY 17, 2022
IG Supplies Safe Despite Big Drop In Plasma/Blood
Despite a recent critical blood shortage and an overall decline in plasma donations since the beginning of the ...
FEBRUARY 11, 2022
Addition of IVIG Does Not Improve COVID-19 Outcomes
Outcomes for patients hospitalized for COVID-19 who received remdesiver plus IVIG were not better than remdesivir ...
JANUARY 28, 2022
Plasma Donation Drop Affecting IG Cost, Not U.S. Supply, Experts Say
Despite a recent critical blood shortage and an overall decline in plasma donations since the beginning of the ...
JANUARY 26, 2022
IG for MIS-C: Lessons Learned
LAS VEGAS—In the spring of 2020, Children’s Hospital New Orleans began using high-dose immunoglobulin ...
DECEMBER 13, 2021
FDA Grants Pediatric Indication for Cutaquig IG for Primary Immunodeficiency
Globally, millions of people suffer with primary immunodeficiencies, a group of more than 400 different diseases. ...
DECEMBER 7, 2021
IVIG for MIS-C Works by Depleting Inflammatory Immune Cells
Intravenous immune globulin (IVIG)—a common treatment for multisystem inflammatory syndrome in children ...
OCTOBER 20, 2021
